tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Balaji Prasad, 21 are a SELL (9.91%), 24 are a HOLD (11.32%), 167 are a BUY (78.77%).
Analyst Balaji Prasad, currently employed at BARCLAYS, carries an average stock price target met ratio of 52.77% that have a potential upside of 23.5% achieved within 291 days.
Balaji Prasad’s has documented 422 price targets and ratings displayed on 28 stocks. The coverage is on Healthcare, Energy sectors.
Most recent stock forecast was given on EOLS, Evolus at 05-Mar-2025.
Analyst best performing recommendations are on LGND (LIGAND PHARMACEUTICALS).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS) at 2/4/2021. The price target of $123.52 was fulfilled within 1 day with a profit of $11.16 (9.93%) receiving and performance score of 99.32.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 06-Feb-2025
$7
$1.98 (39.44%)
$8
1 months 8 days ago
(25-Feb-2026)
1/6 (16.67%)
$0.89 (14.57%)
190
Hold Since 29-Jul-2022
$10
$4.98 (99.20%)
$8.5
11 months ago
(02-May-2025)
14/27 (51.85%)
$4.58 (84.50%)
166
Sell Since 02-Aug-2024
$3
$-2.02 (-40.24%)
$9
1 years 8 months ago
(02-Aug-2024)
12/15 (80%)
$-2.63 (-46.71%)
185
Hold Since 25-Jul-2024
$7
$1.98 (39.44%)
1 years 8 months 8 days ago
(25-Jul-2024)
1/1 (100%)
$1.12 (19.05%)
53
Buy Since 26-Apr-2019
$16
$10.98 (218.73%)
$37
2 years 6 months 13 days ago
(20-Sep-2023)
4/6 (66.67%)
$7.66 (91.85%)
196
What Year was the first public recommendation made by Balaji Prasad?
